Norway · Delayed Price · Currency is NOK Nykode Therapeutics AS Statistics
Total Valuation
OSL:NYKD has a market cap or net worth of NOK 1.13 billion. The enterprise value is 708.74 million.
| Market Cap | 1.13B |
| Enterprise Value | 708.74M |
Important Dates
The next confirmed earnings date is Wednesday, November 25, 2026.
| Earnings Date | Nov 25, 2026 |
| Ex-Dividend Date | May 27, 2025 |
Share Statistics
OSL:NYKD has 326.55 million shares outstanding.
| Current Share Class | 326.55M |
| Shares Outstanding | 326.55M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -12.66% |
| Owned by Insiders (%) | 0.78% |
| Owned by Institutions (%) | 32.73% |
| Float | 214.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 246.88 |
| PB Ratio | 1.43 |
| P/TBV Ratio | 1.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 154.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.52, with a Debt / Equity ratio of 0.02.
| Current Ratio | 11.52 |
| Quick Ratio | 11.52 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -273.73 |
Financial Efficiency
Return on equity (ROE) is -25.06% and return on invested capital (ROIC) is -72.81%.
| Return on Equity (ROE) | -25.06% |
| Return on Assets (ROA) | -17.48% |
| Return on Invested Capital (ROIC) | -72.81% |
| Return on Capital Employed (ROCE) | -33.74% |
| Weighted Average Cost of Capital (WACC) | 8.89% |
| Revenue Per Employee | 77,904 |
| Profits Per Employee | -3.85M |
| Employee Count | 59 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -13.23M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +106.48% in the last 52 weeks. The beta is 0.86, so OSL:NYKD's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +106.48% |
| 50-Day Moving Average | 3.82 |
| 200-Day Moving Average | 3.23 |
| Relative Strength Index (RSI) | 38.38 |
| Average Volume (20 Days) | 1,381,308 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSL:NYKD had revenue of NOK 4.60 million and -227.37 million in losses. Loss per share was -0.72.
| Revenue | 4.60M |
| Gross Profit | 4.60M |
| Operating Income | -273.87M |
| Pretax Income | -240.60M |
| Net Income | -227.37M |
| EBITDA | -266.84M |
| EBIT | -273.87M |
| Loss Per Share | -0.72 |
Balance Sheet
The company has 443.70 million in cash and 17.68 million in debt, with a net cash position of 426.01 million or 1.30 per share.
| Cash & Cash Equivalents | 443.70M |
| Total Debt | 17.68M |
| Net Cash | 426.01M |
| Net Cash Per Share | 1.30 |
| Equity (Book Value) | 796.29M |
| Book Value Per Share | 2.44 |
| Working Capital | 435.93M |
Cash Flow
In the last 12 months, operating cash flow was -268.90 million and capital expenditures 9,906, giving a free cash flow of -268.89 million.
| Operating Cash Flow | -268.90M |
| Capital Expenditures | 9,906 |
| Depreciation & Amortization | 6.83M |
| Net Borrowing | -11.18M |
| Free Cash Flow | -268.89M |
| FCF Per Share | -0.82 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -5,958.41% |
| Pretax Margin | -5,234.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 28.78%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 28.78% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 28.78% |
| Earnings Yield | -20.04% |
| FCF Yield | -23.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for OSL:NYKD is 6.25, which is 79.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 6.25 |
| Price Target Difference | 79.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 165.25% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on July 7, 2020. It was a forward split with a ratio of 5.
| Last Split Date | Jul 7, 2020 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
OSL:NYKD has an Altman Z-Score of 7.88.
| Altman Z-Score | 7.88 |
| Piotroski F-Score | n/a |